Evidence map›Paper›PMID 41171064›Full record

ArticleJournal of managed care & specialty pharmacy2025

Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021.

Devika A Shenoy, Lauren Wilson, Joel Farley, Lynn DeGuzman, Margie Snyder, Antoinette B Coe, Lisa E Hines, Nicole Brandt, Andrea DeVries, Anna Hung

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Devika A ShenoySchool of Medicine, Duke University, Durham, NC.
Lauren WilsonDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC.
Joel FarleyDepartment of Pharmaceutical Care & Health Systems, University of Minnesota College of Pharmacy, Minneapolis.
Lynn DeGuzmanThe Permanente Medical Group, Pleasanton, CA.
Margie SnyderCollege of Pharmacy, Purdue University, West Lafayette, IN.
Antoinette B CoeDepartment of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor.
Lisa E HinesPharmacy Quality Alliance, Alexandria, VA.
Nicole BrandtLamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore.
Andrea DeVriesHumana Healthcare Research, Louisville, KY.
Anna HungDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComprehensive medication reviews (CMRs) are a cornerstone of medication therapy management (MTM) for millions of Medicare Part D beneficiaries, designed to optimize medication use and health outcomes. However, uptake is inconsistent, with known disparities affecting groups such as Asian, Black, and Hispanic patients.

objectiveTo evaluate CMR trends from 2013 to 2021, analyzing changes in provider types, delivery methods, and recipients, with a particular focus on variations across Asian, Black, Hispanic, and White beneficiaries.

methodsEmploying a serial cross-sectional design, we analyzed Part D MTM program data submitted to the Centers for Medicare & Medicaid Services (CMS) from 2013 through 2021, covering all MTM-eligible Medicare beneficiaries. To explore differences based on race and ethnicity, this dataset was linked with a 5% random sample of Medicare fee-for-service beneficiaries. Descriptive statistics were used to evaluate year-over-year trends in CMR provider categories, the methods of service delivery, and the individuals who received the CMR.

resultsThe volume of completed CMRs expanded more than 4-fold, increasing from 526,150 encounters in 2013 to more than 2 million by 2020, before a slight decrease in 2021. The proportion of CMRs delivered by plan or pharmacy benefit manager pharmacists declined from 40% in 2013 to 29% in 2021, and the share of reviews provided by MTM vendors and other pharmacist categories generally increased over the same period. Telephone consultations, already the primary mode of delivery, increased their share from 86% to 96% of all CMRs, whereas face-to-face services correspondingly decreased from 14% to 4% across all racial groups. The decline in face-to-face services was steepest for Asian (from 18% in 2013 to 7% by 2021) and Hispanic patients (from 18% in 2013 to 3% by 2021). Black individuals consistently had the highest rates of direct beneficiary involvement (88% in 2021) and the lowest caregiver use.

conclusionsThe substantial growth in CMR services represents a positive development in patient care. Nevertheless, the marked shifts toward telephonic delivery and changes in the types of providers and recipients engaged highlight a critical need for ongoing assessment.

Indexed as

EthnicityMedicare Part DMedication Therapy ManagementRacial GroupsAgedCross-Sectional StudiesFee-for-Service PlansFemaleHealthcare DisparitiesHumansMaleUnited States

Identifiers

PMID41171064
PMCPMC12577724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.